NEWS
Good News | K-VisionMax™ Peripheral IVUS System Approved for Market Launch, Empowering Precision Diagnosis and Treatment!
Previously, Kossel Medtech (Suzhou) Co., Ltd. (hereinafter referred to as “Kossel Medtech”) completed the strategic acquisition of the peripheral vascular intervention business of Shanghai Biotriton
Kossel Acquires XINZHI MEDICAL to Expand Drug-Coated Balloon Portfolio and Strengthen Its Position in Coronary Intervention
Introduction Kossel Medtech (Suzhou) Co., Ltd. (“Kossel”) has completed the acquisition of Shanghai Xinzhi Medical Technology Co., Ltd. (“XINZHI MEDICAL”), marking a key strategic step
Kossel × Biotriton: Deepening the Peripheral Vascular Intervention Ecosystem and Advancing a Long-Term, Sustainable Growth Strategy
The history of the global medical device industry demonstrates that mergers and acquisitions are a defining pathway for the growth of leading enterprises. International companies
Riding the Waves Globally, Building Strength Worldwide | Kossel Medtech Concludes a Successful Exhibition at EuroPCR 2026
From May 19 to 22, EuroPCR 2026, one of the world’s most influential annual events in interventional cardiology, was grandly held in Paris, France. As
Exciting News | Seledora® Coronary Scoring Balloon Dilatation Catheter Approved by CE MDR, Marking Another Key Milestone in Kossel’s Global Expansion
Recently, Seledora® Coronary Scoring Balloon Dilatation Catheter, independently developed by Kossel’s subsidiary Mixin Medtech, successfully obtained the EU CE MDR certification. This achievement signifies that
Good News | MiStent® Coronary Drug-Eluting Stent Approved, Offering a New Clinical Option for PCI!
Recently, MiStent® Sirolimus Eluting Absorbable Polymer Coronary Stent System, the flagship product of Mixin Medtech, a subsidiary of Kossel Group, has been successfully approved for